Dr. Reddy’s Settles Patent Suit With Celgene Over Cancer Drug
The logo of Dr. Reddy’s Laboratories is seen on a strip of capsules in an arranged photograph in Mumbai, India. (Photographer: Adeel Halim/Bloomberg)

Dr. Reddy’s Settles Patent Suit With Celgene Over Cancer Drug

Dr. Reddy’s Laboratories Ltd. settled its litigation with Celgene Corp. for patents for the generic version of a prescription medicine used to treat blood cancer in a potential boost to its earning...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.